Business Monitor International

Pharmaceuticals & Healthcare Reports

Brazil Pharmaceuticals & Healthcare Report

Published: 29 Jun 2010 Quarterly

Report Downloads

Independent 5-year pharmaceutical and healthcare industry forecasts for Brazil.
Original pharmaceutical and healthcare market research and pharmaceutical and healthcare sector trend analysis for the Brazilian pharmaceutical and healthcare industry.
Competitive intelligence, Brazilian pharmaceutical and healthcare company rankings and SWOT analyses on international and domestic pharmaceutical and healthcare companies in the Brazilian market.

Includes 3 quarterly updates

Price: $975.00

You save $175.00 (15%) on the regular rate

Order Now

Online >>
Order Form >>
Email >>
+44 20 7246 1403

Related Products

Brazil Products

Brazil Business Forecast Report

The Brazil Business Forecast Report provides essential macroeconomic, political and financial analysis for companies doing business in Brazil. Read More

Multinational Companies in Brazil CD-ROM

The Brazil database features 3770 fully researched, senior executive contacts and top decision makers at 1130 multinational companies in Brazil, across 34 industry sectors. Read More

Pharmaceuticals & Healthcare Products

Argentina Pharmaceuticals & Healthcare Report

The Argentina Pharmaceuticals & Healthcare Report has been researched at source and features the latest available data and forecasts to end-2012, covering drugs and healthcare expenditure, the prescription, OTC and generics markets, and foreign trade. Read More

Central America Pharmaceuticals & Healthcare Report

When taken as a whole, the pharmaceutical market of Central America is an attractive prospect for drugmakers. Combined sales of prescription drugs and over-the-counter (OTC) medicines are forecast to increase from US$2.35bn in 2009 to US$2.49bn in 2010. This equates to respectable 6.1% growth and makes Central America’s pharmaceutical market the sixth-largest in Latin America, behind Puerto Rico (US$2.71bn) and ahead of Colombia (US$2.24bn). Read More

Report Description

The Brazil Pharmaceuticals and Healthcare Report has been researched at source and features the latest available data and forecasts to end-2014 covering drugs and healthcare expenditure, the prescription, OTC and generics markets, and foreign trade; company rankings and competitive landscapes including multinational and national drugs companies; and analysis of latest industry news, trends and regulatory developments.

Business Monitor International’s Brazil Pharmaceuticals and Healthcare Report provides industry professionals, market investors and corporate and financial services analysts with independent forecasts and competitive intelligence on the Brazilian pharmaceutical and healthcare industry.

Key Benefits of Report

Benchmark BMI’s Independent 5-year Pharmaceutical and Healthcare Industry Forecasts on Brazil to test other views – a key input for successful budgeting and strategic business planning in the Brazilian pharmaceutical and healthcare market.
Target Business Opportunities & Risks in the Brazilian Pharmaceutical and Healthcare Sector through our reviews of latest industry trends, regulatory changes and major deals, projects and investments in Brazil.
Exploit The Latest Competitive Brazilian Pharmaceutical and Healthcare Intelligence & company SWOTS on your competitors and peers through company rankings by sales, market share and ownership structure – includes multi-national and national companies in Brazil.

Coverage

Executive Summary & Industry SWOT

An at-a-glance perspective on latest regulatory developments, key forecast indicators and major corporate developments, covering the prescription, OTC and generics markets. The SWOT outlines strategic factors which affect BMI’s forecast analysis, and taken together with BMI’s Economic and Business Environment SWOTS, give a complete overview of market climate.

Market Summary

Outline of market characteristics, growth factors, leading therapeutic segments and a competitivness of the market.

Regulatory Regime

Guide to and analysis of country intellectual property developments and pricing & reimbursement issues, which constitute the regulatory make-up of the market.

Industry Developments

Focus on government healthcare reforms, epidemiological trends, company M&As, product launches, market entries, FDI activity, R&D and patent legislation.

BMI 5-Year Industry Forecast

5-Year Forecasts to end-2014 for all key industry indicators (see list below), supported by explicit assumptions, plus analysis of key downside risks to the main forecast, including:

Drug market expenditure (US$bn); drug expenditure per capita (US$); as % of gdp
Prescription drug market (US$bn)/as % of total market; sales by alimentary tract/metabolism; antibiotics, cardiovascular, central nervous system, oncology, musculoskeletal and respiratory system
OTC market (US$bn)/as % of total market (sales by analgesic, cough and cold, digestives, skin treatments, vitamins and minerals)
Generics market (US$bn)/ as % of total market
Health expenditure (US$bn, % of gdp and per capita); public sector health expenditure as % of total; number of hospitals; beds, hospital admissions, doctors, births and deaths per 000 population

Forecasts based on bespoke BMI economic modelling, using historical data sets of macroeconomic and industry variables to derive rigorous statistical relationships, anchored in advanced linear regression techniques.

BMI 5-Year Macroeconomic Forecasts

BMI forecasts for all headline macroeconomic indicators, including:
Nominal and real GDP, % real GDP growth, % private consumption growth, % industrial output growth, % consumer price index, % GDP price deflator, exports, imports, trade balance, current account balance, foreign direct investment, exchange rate against US$, government expenditure, external debt

Competitive Landscape & Profiles

Intelligence on the market position of major MNC power houses and indigenous companies. BMI profiles key research-based companies. Company SWOTS are provided for all key strategic players, complete with a company activity overview, its leading products and analysis of business opportunities.